LJ 001
CAS No. 851305-26-5
LJ 001 ( LJ001 | LJ-001 )
产品货号. M16184 CAS No. 851305-26-5
LJ 001((LJ-001,LJ001)是一种广谱抗病毒剂,针对包膜病毒的进入。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1311 | 有现货 |
|
| 10MG | ¥2119 | 有现货 |
|
| 25MG | ¥3469 | 有现货 |
|
| 50MG | ¥4948 | 有现货 |
|
| 100MG | ¥6552 | 有现货 |
|
| 200MG | ¥8811 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LJ 001
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LJ 001((LJ-001,LJ001)是一种广谱抗病毒剂,针对包膜病毒的进入。
-
产品描述LJ 001 ((LJ-001, LJ001)?is a broad-spectrum antiviral agent targeting entry of enveloped viruses, including influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses, flaviviruses, and HIV-1; specifically intercalates into viral membranes, irreversibly inactivates virions while leaving functionally intact envelope proteins, and inhibits viral entry at a step after virus binding but before virus-cell fusion; specifically inhibits virus-cell but not cell-cell fusion.
-
体外实验Cell Viability Assay Cell Line:ST cells Concentration:0.782, 1.563, 3.125, 6.25, 12.5, 25, 50, 100, 200 μM Incubation Time:24 h Result:Showed slight cytotoxicity with a CC50 value of 146.4 μM.Western Blot Analysis Cell Line:ST cells Concentration:12.5 μM Incubation Time:12, 24 h Result:Decreased the expression of TGEV N protein and PDCoV N-protein at 24 h and markedly reduced TCID50 titers at 12 and 24 h.RT-PCR Cell Line:ST cells Concentration:12.5 μM Incubation Time:1, 6, 12, 24 h Result:Inhibited TGEV and PDCoV gene mRNA expression in a time-dependent manner.
-
体内实验Animal Model:Female BALB/c mice Dosage:20, 50 mg/kg Administration:Oral gavage or i.p.; daily for 7 days Result:Revealed no abnormalities except a slight elevation in serum cholesterol levels in the treated vs. vehicle control group.
-
同义词LJ001 | LJ-001
-
通路Microbiology/Virology
-
靶点Influenza Virus
-
受体Influenza Virus
-
研究领域——
-
适应症——
化学信息
-
CAS Number851305-26-5
-
分子量327.42
-
分子式C17H13NO2S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (305.42 mM)
-
SMILESO=C1N(CC=C)C(S/C1=C\C2=CC=C(C3=CC=CC=C3)O2)=S
-
化学全称(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Wolf MC, et al. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3157-62.
2. Vigant F, et al. PLoS Pathog. 2013;9(4):e1003297.
3. Balmer BF, et al. J Virol. 2017 Jan 31;91(4). pii: e02181-16.
产品手册
关联产品
-
3-?Phenyl-?N-?[1-?(p...
3-?苯基-?N-?[1-?(苯基甲基)?-?4-?哌啶基]?-三环[3.3.1.13,?7]?癸烷-?1-?甲酰胺,具有抗埃博拉病毒的活性靶向表面暴露的糖蛋白并抑制病毒进入宿主细胞。 Vero 细胞体外研究表明,该化合物可抑制病毒复制,EC50 为 0.38 μM。
-
Peramivir
Peramivir (RWJ-270201、BCX-1812) 是一种流感神经氨酸酶抑制剂,可防止新病毒颗粒的释放;用于治疗和预防甲型流感和乙型流感的抗病毒剂。
-
Molnupiravir
Molnupiravir (EIDD-2801) 是核糖核苷类似物 EIDD-1931 的口服生物可利用的异丙酯前体。Molnupiravir 显示出广泛的抗流感病毒 (influenza virus) 和coronaviruses的活性,如 SARS-CoV-2,MERS-CoV,SARS-CoV。Molnupiravir 有用于 COVID-19 和季节性,流行性流感的潜力。
021-51111890
购物车()
sales@molnova.cn

